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A modified solid phase competitive enzyme labelled immunoassay (ELISA)
for progesterone using whole plasma is described.Microtitre plates were
coated with a 1:5000 dilution of rabbit anti-progesterone-11-BSA andstored
at 4 C for approximately 12 hours.After the plates were washed,
progesterone standards diluted in whole plasma and wholeplasma samples
were added, followed by the addition of a 1:20,000dilution of progesterone-3-
0-carboxymethyloxime horseradish peroxidase as the steroid enzyme conjugate.
Plates were covered and incubated for 2 h at room temperature.Following
incubation and washing, the substrate, 2,2'-azino-bis(3-ethylbenz-thiazoline-6-
sulphonic acid) was added and allowed to react for approximately 45 min to 1
h.Plate absorbance was read at 405 nm. The sensitivity of the assay was
19.5 pg/well or .391 ng/ml, with the standard curve usable to 25 ng/ml.
Progesterone of 5, 10 and 15 ng/ml were added to whole plasma to determinerecovery, which was linear(y = -.062 + .984x).Intra- and interassay
coefficients of variation for low and high (5 and 15 ng/ml) progesterone were
4.4, 3.5 and 9.1, 15.5, respectively.Of nine structurally related steroids
tested for cross reactivity, 5a-pregnane-3,20-dione (5aDHP) reacted at 23.9 %
and pregnenolone at .5 %. All other steroids did not significantly cross react
( < .1%). A commercially available radioimmunoassay (RIA) was used to test
standards diluted in human serum, charcoal extracted or equine whole plasma.
A one-way analysis of variance followed by least significant difference (LSD)
indicated that standards dilutedin charcoal extracted plasma measured
progesterone concentrations lower (P < .05) than human serum or whole
plasma.
Normal pregnant mare samples were assayed using standards diluted in
charcoal extracted or whole plasma.Plasma progesterone measured using
standards diluted in charcoal extracted plasma were low and inconsistent with
other reports.A paired t-test indicated that there was a difference in
progesterone concentrations when using standards diluted in charcoal extracted
or whole plasma (P< .05).Results by analysis of variance indicated a
difference in plasma progesterone over time, using standards. diluted in charcoal
extracted or whole plasma (P< .05). These results indicated that treatment of
standard and sample plasma must be the same. Overall, plasma progesterone
concentrations using standards diluted in whole plasma were similar to values
reported using RIA and competitive binding radioassay methods.
Plasma progesterone was measured from four normal pregnant mares fromDay 0 to 200 using standards diluted in whole plasma. The levels and pattern
were similar to those previously reported.Plasma progesterone was also
determined from two mares treated with 5aDHP and one mare with
prostaglandin-F2a (PGF2a).Progesterone decreased to 0 ng/ml within 48 h
following luteolysis with PGF2a. Plasma progesterone decreased one and two
days following PGF2a in both mares treated with 5aDHP but never reached 0
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INTRODUCTION
Plasma progesterone during the estrous cycle and pregnancy was first
measured by Short (1959) using ultraviolet absorption technique. Because of
thelimiteddetection of thistechnique, other methods for measuring
progesteronesuchasradioimmunoassay(RIA)andenzymelabelled
immunosorbent assay (ELISA) were developed. Due to the concerns associated
with the use of RIA such as handling and disposal of radioactive material, the
development of an alternate method that would be equal to or superior to RIA
was attempted.
The ELISA was first introduced in the field of endocrinology in the early
1970's. Since then, it has become increasingly popular in many disciplines.
Enzyme immunoassay systemshavebeendevelopedformeasuring
progesterone in plasma and milk of many domestic species.Some of the
ELISA's utilize whole plasma, but many still require ether extraction of samples.
Enzyme immunoassay systems specifically developed (and validated for use in
horses) to measure plasma progesterone concentrations in the horse appear to
be few. A commercially available enzyme immunoassay kit (Enzygnost Serum
Progesterone testkit,distributed by Hoechst-Roussel Agri-Vet company,
Somerville, NJ) which has been validated for measuring plasma progesterone
in the horse, is not always easily obtained and more expensive when assaying2
large quantities of samples for research purposes.Seeger et al. (1979)
developed an ELISA for progesterone in horse plasma. The assay appeared to
measure progesterone concentrations similar to those measured by RIA, but
was less sensitive and involved extraction of samples. Bosch et al. (1978)
developed an ELISA for measuring total estrogens in serum or plasma during
pregnancy.The results were similar to those obtained by RIA, but also
involved sample hydrolysis and dilutions to avoid interference of plasma factors.
The goal of this thesis work was; 1) To adapt a workable ELISA for our
laboratory in which whole plasma is used, eliminating the cumbersome process
of ether extraction; and, 2) To measure progesterone concentrations of whole
plasma samples from mares during different physiological states such as early
pregnancy (ovulation to Day 200) and following treatment of 5aDHP and
PGF2a.This would demonstrate that the assayismeasuring plasma
progesterone concentrations consistent with those reported in the literature.3
LITERATURE REVIEW
Introduction
The mare is known as a long-day polyestrous seasonal breeder with fertile
estrous cycles in the spring and summer (Hines, 1987). The gestational length
of the mare is approximately 11 mo or 335 to 345 d.Due to this long
gestational period and the arbitrary assignment of January 1 as the birth date
for foals born within a year, a demand has been stimulated by the equine
industry for advancing the onset of the natural breeding season (Hart et al,
1984).In northern latitudes, reproductive cyclicity occurs from early May to
October (Ginther, 1974).Research in the last two decades has led to the
acceptance of photoperiod as the primary stimulus for the regulation of
seasonal reproduction in birds and mammals (Hart et al., 1984). Photoperiod
is the main factor that influences the mare's reproductive cycle. Maximum and
minimum ovulatory activity coincides with the time of long and short daily
photoperiods, respectively (Freedman et al., 1979). Sharp and Ginther (1975),
and Kooistra and Ginther (1975), showed that the onset of the ovulatory
season in pony mares can be hastened by approximately two months by
exposing mares during the anovulatory season to spring environmental
conditions ofartificiallong daily photoperiod.Oxender etal.(1977),
demonstrated that a 16 h photoperiod exposure to anestrous mares in
December caused normal cycles to begin in two months.4
Tissue Control of Reproductive Activity
The four tissues that play a vital role in controlling reproductive processes
are the pineal gland, hypothalamus, pituitary, and gonads.
The pineal gland, located above the thalamus and attached to the roof of
the third ventricle, is largely responsible for controlling reproductive seasonality
(Hines, 1987). The pineal acts as a mediator between the light receptors and
the hypothalamic-pituitary axis, by converting a neural input to a hormonal
output (Ginther, 1979).Light enters the retina of the eye and travels to the
pineal via a neural pathway. As the mare perceives increasing photoperiod,
secretion of the antigonadal factor melatonin, produced by the pineal, is
inhibited, which allows an increase in gonadotropic releasing hormone (GnRH)
from the hypothalamus. This releasing hormone (GnRH) travels to the anterior
pituitary via the portal system to activate an increase in gonadotropic hormone
release from the anterior pituitary. The gonadotropic hormones released from
the anterior pituitary travel through the general circulation to the ovaries and
stimulate their function.
The hypothalamus through the action of GnRH, which is released in a
pulsatile manner, controls the release of the gonadotropins follicle stimulating
hormone (FSH) and luteinizing hormone (LH) (Hines, 1987). The hypothalamic
content and secretion of GnRH is decreased during anestrus compared to the
breeding season (Johnson, 1987). Although the secretion of GnRH varies with5
season, the total GnRH receptor number in the pituitary remains unchanged
(Johnson, 1987). This would indicate that seasonal anestrus is the result of
decreasing amounts of GnRH released from the hypothalamus and not due to
pituitary responsiveness to GnRH.
Two important hormones released from the anterior pituitary are LH and
FSH. These are glycoprotein hormones each containing two subunits, a and
13,in which the a subunits are similar within species but with differing
subunits.Itis the R subunits that regulate the binding of the hormone to
various target cells and define the biological function of each hormone.In
comparison to other species, a pulsatile release of LH and FSH are not usually
found to occur in the mare. However, reports by Irvine (1984) and Fitzgerald
et al. (1985) have indicated that LH and FSH may be released in a pulsatile
manner. Equine LH differs from the LH of other species in that it contains a
large amount of sialic acid (6-7%), which renders unusual properties to the LH
molecule (Irvine, 1984). This high amount of sialic acid allows the LH molecule
to interact with or locate target molecules in the gonadal (ovarian) cells and
contributes to the high biological potency and long circulatory halflife of 5 h.
This is in comparison to human LH halflife of 2 h (sialic acid 2%) and ovine LH
halflife of 20-30 min (no sialic acid). The FSH molecule from all species has 5-
7% sialic acid and about the same halflife as each corresponding LH halflife
(Irvine, 1984).
There are several unique properties concerning LH in the mare as reported6
by Irvine (1984).First, the preovulatory phase of the LH surge is prolonged
encompassing 6 d, in comparison to 1 d in other species. Secondly, LH levels
continue to rise 1-2 d postovulation instead of declining up to 24 h before
ovulation, as in most species.Thirdly, LH levels decline slowly to baseline
levels.Therefore, in the mare, the function of LH is similar to other species
except that there is a very slow rise which extends follicular maturation and the
length of estrus. The rate of FSH and LH release are regulated by the amount
of GnRH that is released from the hypothalamus, which varies with season.
Alexander and Irvine (1986) found that the amount of LH released in response
to a similar dose of GnRH was similar in anestrus compared to cycling mares.
Thus, the pituitary seems capable of releasing LH and/or FSH, but the
decreased release of GnRH depresses pituitary release of FSH and LH.
Estrous Cycle and Ovulation
The length of the estrous cycle in the mare is approximately 21 d with
estrus lasting 6 d and diestrus 15 d. On the average, the estrous cycle is two
days longer in ponies than in horses (Ginther, 1979).In one published study
by Ginther (1979), the length of the interovulatory interval was 22.7 ± 0.7 d
(mean ± SEM) for horses and 25.0± 0.6 d for ponies.
Ovulation usually occurs 24 h before the end of estrus.A distinctive
feature of ovulation in the mare, compared to that in other species, is the7
occurrence of ovulation from a specialized area, the ovulation fossa.The
cortical and noncortical areas of the adult mare's ovaryisunusualin
comparison to other species. One would normally expect the medullary region
of the ovary to be the soft region in the center of the ovary and the cortical
region to be the outer portion. However, this is not true of the equine ovary.
The ovary of the adult mare is structured so that the medullary region is
superficial and the cortical region, which contains the follicles (parenchyma),
is in the interior of the organ. The parenchyma reaches the surface only at the
depression (ovulation fossa) from which normal ovulation occurs.Because
ovulation occurs inward, itis more difficult to detect the corpus luteum by
rectal palpation.Ovulation occurs due to a reduction in the strength of the
rupturing point (ovulation fossa) by proteolytic enzymes (Ginther, 1979). The
hormonal stimulant that most likely allows ovulation to occur is LH. Right after
ovulation takes place, a structure known as the corpus hemorrhagicum, forms.
The corpus hemorrhagicum is a fluid filled (primarily blood) structure that
precedes the formation of the corpus luteum or CL also known as a "yellow
body".The CL is the primary source of progesterone secretion and very
necessary for the maintenance of early pregnancy in the mare.8
Endocrinology of Pregnancy
After fertilization has occurred, the conceptus takes approximately 4 to 5
d to travel down the oviduct into the uterus. At this time the conceptus is
completely mobile and is free to migrate between the right and left uterine
horns. Maternal recognition of pregnancy occurs between Day 14 and 16, as
reported by Hershmann and Douglas (1979), but may be as early as Day 11 to
13 (Betteridge et al., 1985; Goff et al., 1987). According to Hershmann and
Douglas (1979), blastocyst removal on Day 16 after ovulation resulted in
pseudopregnancy characterized by a prolonged interestrous interval, prolonged
interovulatory interval and the maintenance of uterine tonicity and continued
progesterone production.Kooistra and Ginther (1976) found that removing
equine embryos surgically on Day 24 resulted in pseudopregnancy and the
continued secretion of progesterone. These results indicated that the cyclic
life-span of the CL is not affected by the presence of the blastocyst within the
mare's uterus until after Day 14 postovulation.
Fixation of the equine blastocyst usually occurs at approximately Day 15 of
gestation (Kastelic et al., 1987).The fetal placenta is composed of three
membranes (amnion, chorion and allantois) and is described as being diffuse
and of the nondeciduate type with superficial villous attachments.True
microvillous attachment of the placenta to the uterine endometrium begins at
approximately Day 35 and is completed by Day 150 of gestation.9
One specialized feature of the mare is the formation of endometrial cups.
The cups are of maternal and fetal origin, that appear as raised areas above the
surface of the endometrium. Formation of the cups are apparent by Day35
and begin to secrete a hormone, pregnant mares' serum gonadotropin (PMSG),
also known as equine chorionic gonadotropin (eCG), unique to the mare.
Pregnant mares serum gonadotropin has primarily FSH activity, peaking in
secretion by Day 60 and virtually undetectable by Day 120 to 150 (Evans et
al., 1990).
The two steroid hormones estrogen and progesterone are present at various
concentrations in the plasma of mares during the estrous cycle and pregnancy.
Allen and Hadley (1973) reported plasma progesterone concentrations during
the estrous cycle to increase on Day 2 postovulation and to be maintained on
a plateau from Day 5 to 14. Diestrus progesterone concentrationsvaried from
6.4 ng/ml to 13.4 ng/ml which occurred between Days 5 and 14. Within 2 to
3 days thereafter, levels dropped to approximately 1ng/ml.If conception
occurred, maximal plasma progesterone concentrations were found to range
from 9.4 ng/ml to 17.4 ng/ml from Day 7 to 17 postovulation.Sato et al.
(1977) reported progesterone concentrations in cycling mares to rapidly
increase between Day, 0 to Day 3 postovulation (4.5 ng/ml, reach maximal
levels between Day 7 and 15 (7.8 ng/ml), and then fall sharply. Progesterone
concentrations remained elevated after Day 15 if the mares were pregnant.
Holtanetal.(1975) measured progesterone concentrations during10
Holtanetal.(1975) measured progesterone concentrations during
pregnancy bycompetitiveproteinbindingradioassay. Progesterone
concentrations were found to increase from 1.1 ± .4 ng/ml on Day 0 to 7.5
± 1.2 ng/ml on Day 8, declining to 4.8 ± .4 ng/ml on Day 28. From Day 28
to 44 progesterone increased, reaching a maximal concentration of 15.2 ± 1.4
on Day 64, then decreased and remained between 1 and 2 ng/ml fromDays
180 to 300. During the last 30 days of gestation, progesterone increased to
4.4 ± 1.1 ng/ml 5 days prepartum, and then dropped to .5 ng/ml 1 to 3 days
postpartum.Ginther (1979) summarized the following changes: Days 0-8,
progesterone concentrations increase similar to the estrous cycle; Days 9 to 27,
slight decrease; Days 28 to 44, increasing; Days 56 to 120, the greatest
concentration; Days 120 to 180, decreasing; Days 180 to 300, very low
concentrations; and the last thirty days, slight increase.After parturition,
progesterone concentrations decrease only after delivery of the placenta as
described by Holtan et al. (1975).
Nett et al. (1973) have shown that plasma estrogens start to increase
approximately by Day 45 of gestation and increase at a rapid rate beginning by
Day 90. Estrogen concentrations continue to rise until Day 210 with maximal
concentrations found at Day 240. This pattern coincides with urinary estrogen
concentrations as described by Cole and Saunder (1935). The concentrations
of estrone (El ), equilin and equilenin remained below 20 pg/ml from breeding
to Day 80 of gestation and then increased to 828 ± 151 pg /mI at Day 210 and11
declined until parturition.The concentration of estradio1-1711 (E2) remained
below 15 pg /mI until Day 90, increased to 71 ± 18 pg/ml at Day 240, declined
until Day 300 and remained unchanged until parturition (Nett et al., 1973).
Progesterone Sources
Progesterone derived either from the CL, placenta or both, have been shown
to be essential for the maintenance of pregnancy in every species ( Sitteri et al.,
1977).As reviewed by Gomes and Erb (1965), maternal ovaries with
functional CL are necessary throughout gestation in the rabbit, sow, goat, cow
and bitch, but for a much smaller proportion of pregnancy in the ewe, primate,
guinea pig, and mare, with the latter species deriving their progesterone from
the placenta. The essential role of the CL was first discovered by Frankel in
1903 as reported by Ginther (1979).The CL is formed at the site where
ovulation occurred. Burns and Fleeger (1975) reported plasma concentrations
of progesterone, produced by the primary CL to reach 13 ng/ml by Day 5
postovulation and persist until Day 30.Sato et al. (1977) reported mean
progesterone concentrations in cycling mares to increase rapidly between Day
0 to 3 postovulation (4.5 ng/ml), were maximal (7.8 ng/ml) between Day 7 and
15, and then fell sharply. In pregnant mares, levels remain elevated after Day
15.According to Ginther (1979) the primary CL ismaintaineduntil
approximately Day 160 to 180 of pregnancy, at which time it regresses. The12
secondary CL, whether or not from an ovulatory or lutenized follicle, begin to
form by Day 40, develop into functional luteal tissue and also regress with the
primary CL by Day 180 (Ginther, 1979).
The placenta takes over progesterone production at some stage during the
first half of gestation (Squires and Ginther, 1975).It is not known exactly
when the ovarian source of progesterone is no longer primarily responsible for
the maintenance of pregnancy, but early reports by Hart and Cole (1934) and
Amoroso (1955) demonstrated that mares who were ovariectomized at Day
150 or 200 of gestation do not abort.More recently, Holtan et al. (1979)
reported that the ovaries of the mare are dispensable between Day 50 and 70
of gestation. This was demonstrated by ovariectomizing mares between Days
50 and 70, of which 11 out of 20 mares maintained pregnancy, in comparison
to all of the mares who were ovariectomized before Day 50 of gestation who
either aborted or resorbed the conceptus.This time period is considerably
earlier than reported by Hart and Cole (1934) and Amoroso (1955).It appears
that the ovarian source of progesterone is critical up to Day 50 of gestation but
that a nonovarian progesterone source is responsible for maintaining pregnancy
after this time (Holten et al., 1979). It was suggested by Short (1957) that the
placenta or conceptus may be the nonovarian source of progesterone which is
not established until after Day 45, as ovariectomized mares maintained with
exogenous progesterone daily from Day 25 to 45 aborted following treatment.13
Progesterone Metabolites
Three progestagen-like compounds have been detected during pregnancy
and have been identified as 5a-pregnane-3,20-dione (5aDHP), 3a-hydroxy-5a-
pregnan-20-one (3(3-0H5aP), and 20a-hydroxy-5a-pregnan-3-one (20a-OH5aP)
by Atkins, et al. (1974), and Holtan et al. (1975).Holtan et al. (1975)
identified 5aDHP and 313-0H5aP and 20a-OH5aP which appear to be of feto-
placental origin.Atkins et al. (1976) confirmed the identification of 5a-
pregnane-3,20-dione in the peripheral circulation of the pregnant mare. Atkins
et al. (1976) detected 5aDHP in the maternal circulation during early pregnancy
(Day 1 to 30) at which time embryo contributions would not be expected to
account for the elevated levels that were detected.Atkins et al. (1976)
demonstrated that blood levels of progesterone and 5aDHP are similar in that
they both decline from Day 10 to Day 40, and then increase. Following the
development of the feto-placental unit (80 days), progesterone concentrations
decline whereas 5aDHP concentrations either increase or are maintained.
Seamans etal.(1979) reported 5aDHP levels to increase to a level of
approximately 133 ng/ml 80 h before parturition and decreased to a level of 9.2
ng/mlinthe postpartum period.Work done by Moss etal.(1979)
demonstrated that progesterone and/or its metabolites are rapidly dispersed into
both the maternal and fetal circulations. Tritiated progesterone was injected
into mares after which blood samples were taken for 6 h from the uterine artery14
and vein and umbilical artery and vein via catheters that were sutured into
place.Blood samples were taken during the first 2 h after injection and the
level of radioactivity associated with each pregnane determined.Results
indicated that umbilical artery levels of 5aDHP are less than umbilical vein
which most likely suggests that this compound is not formed in the fetus.
Evidence for aplacental source of 5aDHP included elevated levels of
nonradioactive 5aDHP in plasma samples from the umbilical and uterine vein at
0 h.The inability to detect nonradioactive 20a-OH5aP at 0 h in umbilical
plasma but with consistent elevation of radioactive 20a-OH5aP from uterine
artery plasma, led to the conclusion that this pregnane is formed primarily from
a maternal source. The level of radioactivity associated with 311-0H5aP in
plasma from the umbilical artery was always greater than in plasma from the
uterine artery and vein. Results from this work suggested that radioactive 311-
OH5aP was formed primarily by the fetus.Holtan et al. (1991) detected
5aDHP and 3R -OH5aP concentrations in plasma of normal pregnant mares
which were similar to progesterone during early pregnancy (Day 10 and on),
but remained elevated to term.These results support the suggestion that
5aDHP (Holtan et al., 1975; Atkins et al., 1976) and 311-0H5aP (Moss et al.,
1979) are of maternal origin, at least during early pregnancy. Other pregnanes
were first detected at 60 d and gradually increased throughout pregnancy, with
a sharp increase the last 30 to 60 d.The predominate pregnane was 20a-
OH5aP which was found to be one of two pregnanes (the other was 5a-15
pregnane-313-20adiol) that were higher than all other steroids from Day 170 to
term. These progestagens in the latter stages of pregnancy, including 5aDHP
and 311-0H5aP, appear to involve the feta-placental unit. The function of these
progestagen-like compounds still remains unclear and further work needs to be
done in identifying their biological activity and function during early and late
pregnancy.
Methods for Measuring Progesterone
Progesterone concentration in the blood of mares during the estrous cycle
and pregnancy was first measured by Short (1959), using an ultraviolet
absorption technique. This technique had a limited detection of approximately
4 ng/ml, which was insufficient for measuring progesterone levels during some
periods of estrus and pregnancy. Since then, quicker and more sensitive assay
systems have been developed such as competitive protein binding assay (CPB),
radioimmunoassay (RIA), and enzyme linked immunosorbent assay (ELISA).
The RIA and ELISA have proven to be accurate, reliable and quick methods
for measuring progesterone and estrogens.However, specificity in the
antibody is needed to eliminate false positives and cross reactivities (Villahoz
et al., 1989).Polyclonal antibodies are currently being used, however, the
results may be an overestimation of the steroid being measured (progesterone)
due to increased level of cross reactivity. Both RIA and ELISA are sensitive16
assays that can detect relatively small amounts of antigen and measure large
quantities of samples rather quickly. Although sensitive and accurate, use of
the RIA requires careful consideration over the ELISA due to such factors as:
a) working with radioactive material; b) short shelf-life of reagents such as 1251
; c) disposal of radioactive material; and, d) expensive equipment to measure
radioactivity.
The ELISA was first introduced in the field of endocrinology in the 1970's.
Since then, it has become increasingly popular. Enzyme immunoassay systems
have been developed for measuring progesterone in plasma and milk of many
domestic species. Some of the ELISA's utilize whole plasma, but many still
require ether extraction of samples. Enzyme immunoassay systems specifically
developed for measuring plasma progesterone in the horse appear to be few.
Seeger et al. (1979) developed an ELISA for measuring plasma progesterone
in the horse, which required ether extraction of plasma samples. Bosch et al.
(1978) developed an ELISA for measuring total estrogens in serum or plasma
during pregnancy in the horse. Results were similar to those obtained by RIA,
but also involved extraction of samples to avoid interference of plasma factors.
More recently, Munro and Stabenfeldt (1984) developed a direct ELISA for
measuring plasma progesterone, but still involved ether extraction of samples.
Although there is a commercial progesterone kit that has been validated for use
in horses, it is not always easily obtained or economically feasible for research
purposes.17
MATERIAL AND METHODS
Animals
Normal mares.Four pony mares weighing approximately 250 kg and of
unknown breeding origin were used. The animals were teased daily with a
stallion to determine estrus and the ovaries examined every day by rectal
palpation and ultrasound (Aloka 210-DX with a 5-MHz probe, Corometrics
Medical Systems, Inc. Wallingford, CT) as described by Ginther (1986).
Ovulation was defined as the disappearance of a large follicle ( > 35mm) and the
subsequent appearance of CL tissue as detected by ultrasoundThe mares
were bred either naturally or by artificial insemination every other day while in
estrus.All mares were examined with ultrasound starting on Day 10 for
confirmation of pregnancy.
Treated mares.Three pony mares of unknown breeding origin and weighing
approximately 250 kg were used. Handling of the animals, blood sampling and
hormone analysis were the same as for normal mares. The treatment that
these mares received was as follows: a) Mare 1received 60 mg of 5a-
pregnane-3,20-dione (5aDHP) i.m. (dissolved in corn oil) starting on Day 10 of
pregnancy with 5 mg of PGF2a given i.m. on Day 12; b) Mare 2 received the
same treatment, but starting on Day 13 of pregnancy with PGF2a given on Day
15.Treatment of 5aDHP was continued for both mares untilloss of18
pregnancy, which was confirmed by ultrasound. Mare 3 was used as a positive
control, with PGF2a given on Day 15 of pregnancy.
Blood Handling
Daily blood samples were collected by jugular venipuncture beginning on
Day 1 of estrus through Day 2 postovulation, every other day until Day 15 of
pregnancy, and then daily to Day 20. From Day 20 to 50 of pregnancy, blood
samples were collected every other day, twice weekly from Day 50 to 80, and
reduced to a weekly basis until parturition. The blood was withdrawn into
evacuated heparinized tubes and immediately centrifuged. The plasma was
removed into plastic vials and stored at -20C until hormone analysis.
ELISA
Reagents. The following reagents were purchased from Sigma Chemical
Company (St. Louis, MO); bovine serum albumin, polyoxyethylene-sorbitan
monolaurate (Tween 20), 2,2'-azino-bis(3-ethylbenz-thiazoline-6 sulfonic acid)
(ABTS), citric acid, hydrogen peroxide, progesterone, 5a-pregnane-3,20-dione,
311-Hyd roxy-5-pregnen-20-one, 5-pregene-311, 2013dio1,313-hydroxy-5a-pregnan-
20-one,20a-hydroxy-5a-pregnan-3-one,5a-pregnane-313,2013-diol,5a-
pregnane-313,20a-diol, and cholesterol.19
Disposable Immulon 4 flat-bottomed polystyrene 96-well microelisa plates
(12.8 x 8.6 cm) and plate sealers (8.26 x 13.34) were purchased from
Dynatech Lab Inc. (Chantilly, VA). A Titertek digital multichannel pipette and
Titertek Multiskan Plus II automatic plate reader were both purchased from
Flow Laboratories (Covina, CA). A commercially available radioimmunoassay,
Coat-A-Count (for progesterone) was purchased from Diagnostic Products
Corporation (Los Angeles, CA).
Stock solutions.The following stock solutions were used in the solid phase
ELISA :1) .05 M bicarbonate coating buffer, pH 9.6; 2) .1 M phosphate buffer
saline, pH 7.0, contained .1 % bovine serum albumin (PBS-BSA); 3) wash
solution contained .05 % polyoxyethylene-sorbitan monolaurate (Tween 20)
and .15 M NaCI; 4) citrate buffer, pH 4.0;5) substrate solution contained 1
ml 2,2-azino-bis(3-ethylbenz-thiazoline-6sulfonic acid) (ABTS), 98.7 ml citrate
buffer and 320 pl of an 8 M hydrogen peroxide solution and was made
approximately 10 min before use.
Antibody.A polyclonal antibody, rabbit anti-progesterone conjugated with
BSA at the 11 position, was a gift from Dr. G. Stabenfeldt ( Univ. Cal, Davis,
CA). An initial 1:10 dilution was made in .1M PBS-BSA with 100 NI aliquots
stored at -70 C until assay.20
Steroid enzyme conjugate. The enzyme-steroid conjugate used was
progesterone-3-CMO-horseradish peroxidase, which was also a gracious gift
from Dr G. Stabenfeldt. As with the antibody, an initial 1:10 dilution in .1 M
PBS-BSA was made with 20 NI aliquots stored at -70 C until assay.
Standards and controls.A 1 mg/ml stock solution of progesterone in ethanol
was first made, from which all standards and quality controls were made. The
plasma that was used to dilute standards and controls was obtained from a
mare in estrus. Dextran coated charcoal was added to plasma to remove free
steroid, fat, fibrin and other components in plasma that may cause interference
of progesterone binding. Standards were diluted in both charcoal extracted and
whole plasma in halving dilutions which ranged from 25 to .391 ng/ml. Quality
controls of 5, 10 and 15 ng/ml were made by adding known amounts of
progesterone to plasma and assayed (in triplicate) on every plate.This was
done to test the assay procedure to measure known added amounts of
progesterone and to determine intra- and interassay variability.
Nonspecific binding.Nonspecific binding was determined by adding 50 p1 of
the following (in duplicate) to each plate during development of the assay; a)
PBS-BSA only; b) PBS-BSA without antibody coating; c) PBS-BSA without
enzyme conjugate; d) plasma only; e) plasma without antibody coating ; and,
f) plasma without enzyme conjugate.21
Sample dilution.If progesterone concentrations exceeded the range of the
standard curve samples were diluted 1:10 and 1:5 with PBS-BSA or 1:5 with
whole plasma.
Steroid cross reactivity.Stock solutions of 1 mg/ml of 9 steroids (listed in
the reagent section) were made in methanol and from which log (1 to 10,000
ng/ml) dilutions in whole plasma were made. These steroids were assayed in
triplicate to determine which steroids cross reacted with the antibody. Other
relatedsteroidssuchascortisol,testosterone,estradio1-1711,and
androstenedione were initially tested by Munro and Stabenfeldt (1984).
Hormone analysis.Progesterone concentrations of normal and treated mares
were measured by a modified solid phase (direct) competitive ELISA (Munro and
Stabenfeldt, 1984) using whole plasma.Various dilutions of antibody and
enzyme conjugate were tried during development of the assay.Standards
diluted in buffer (PBS-BSA) were first used to determine which dilution of
antibody and enzyme conjugate would produce a curve with an optimal slope.
Since the purpose of developing this assay system was
to use plasma and avoid ether extraction, further development with buffer
standards was eliminated. Standards diluted in charcoal extracted plasma and
whole plasma were also tested at various antibody and conjugate dilutions.
Disposable lmmulon 4 flat-bottomed polystyrene 96-well microelisa plates22
were coated with 50 pi per well of a 1:5,000 dilution of BSA-adsorbed rabbit
anti-progesterone in .05 M bicarbonate buffer pH 9.6. The plates were covered
with plate sealers and stored at 4 C for approximately 12 h before assay. To
remove excess unbound antibody, the plates were individually washed 5x with
wash solution, inverted and blotted dry.Fifty pl of .1 M PBS-BSA was added
to each well on the plate, followed by the addition of 50 pi whole plasma
standards or sample (in triplicate), followed by an additional 50 pl of a
1:20,000 dilution of the steroid enzyme conjugate in .1 M PBS-BSA. Plates
were covered and allowed to incubate for 2 h at room temperature. Following
incubation, plates were washed 5x, inverted and blotted dry. One hundred pl
of substrate solution was added to each well on the plate. After an incubation
period of approximately 45 min, plate absorbance was read at 405 nm with a
Titertek Multiskan PlusII automatic plate reader.A standard curve was
calculated by plotting absorbance against log progesterone concentrations of
standards, using a logistic curve-fitting program, Titersoft E.I.A. software
version 2.0A (Flow Laboratories, Covina, CA).
Radioimmunoassay. A commercially available RIA was used to compare
standards diluted in human serum, charcoal extracted and whole plasma. This
was done to determine if the three types of standards were measuring plasma
progesterone concentrations of whole plasma samples from mares during early
pregnancy (Day 0 to 200) the same.23
Statistical Analysis
Sample assay variability and quality controls were analyzed by conventional
statistical programs (means ± sem, coefficient of variation, and linear
regression). All other statistical analysis was done using SAS program (SAS
Institute Inc., Cary, NC) with the exception of a t-test which was hand
calculated to determine sensitivity of the assay. GLM-ANOVA with repeated
measures was used to compare sample plasma progesterone concentrationsof
pregnant mares using standards diluted in charcoal extracted or whole plasma.
A one-way ANOVA was used to test plasma progesterone concentrations from
pregnant mares measured by RIA using standards diluted in human serum,
charcoal extracted or whole plasma.Differences were tested with least
significant difference (LSD).A paired t-test was done to test plasma
progesterone concentrations of individual mares using standards diluted in
charcoal extracted and whole plasma.A t-test was done to determine
sensitivity of the assay using standards diluted in whole plasma ( Zar, 1984).24
RESULTS AND DISCUSSION
Assay
Standards initially diluted in buffer (PBS-BSA) were used to determine
dilutions of antibody and enzyme conjugate that would produce an optimal
standard curve.Results indicated that a 1:5,000 antibody dilution and
1:20,000 enzyme conjugate dilution were appropriate. Further development
of the assay was accomplished using standards diluted in charcoal extracted
plasma.It was determined early in development that buffer (PBS-BSA) must
be added to each well on the plate prior to the addition of standard or sample.
Prior to this step, a standard curve comparable to that using standards diluted
in buffer (PBS-BSA) was not achieved. The addition of buffer appeared to
decrease variability within and between assays.
Plasma in which standards were diluted was charcoal extracted to eliminate
existing components in plasma such as free steroids, fat and fibrin that may
interfere with progesterone binding to the antibody. An optimal standard curve
was achieved using antibody and enzyme conjugate dilutions described for
standards diluted in buffer.Figure 1represents a standard curve utilizing
standards dilutedin charcoal extracted plasma.The average intra- and
interassay coefficient of variation was 4.8 and 6.0, and 12.2 and 12.3,
respectively. Quality control (0, 5, 10, and 15 ng /mI of progesterone added to
plasma) results appeared to indicate that the assay was measuring known25
added amounts of progesterone adequately (y = -.062 + .984x). However,
when whole plasma samples were assayed using standards diluted in charcoal
extracted plasma, results were low and inconsistent with other reports. Due
to the low and inconsistent results using standards diluted in charcoal extracted
plasma, whole plasma samples were reassayed using standards diluted in whole
plasma. Figure 2 represents a standard curve using standards diluted in
whole plasma. The readable portion of the standard curve ranged from .391
ng/ml to approximately 25 ng/ml. The sensitivity of the assay using standards
diluted in whole plasma was 19.5 pg/well or .391 ng/ml which was determined
by a t-test and defined as the first progesterone standard different from zero;
P < .05.Munro and Stabenfeldt (1984) reported their assay to have a
sensitivity of .25 pg/ml. Plasma progesterone concentrations less than 1 ng/ml
are not usually found during early pregnancy. Therefore, a sensitivity of less
than 1 ng/ml was not of importance and further attempts to increase sensitivity
was not done.Whole plasma quality control (5,10, and 15 ng/ml of
progesterone) results indicated that the assay was measuring known added
amounts of progesterone adequately (Figure 3).The intra- and interassay
coefficient of variation for low and high progesterone concentrations (5 and 15
ng/ml) were 3.5 and 4.4 and 9.1 and 15.5, respectively.
Nine structurally related steroids listed in Table 1 were tested for cross
reactivity. Compared to progesterone at 100 %, 5aDHP reacted at 23.9 % and
311-hydroxy-5-pregnen-20-one (pregnenolone) at .5 %. All other steroids listed26
did not significantly react ( < .1 %). Munro and Stabenfeldt (1984) reported
5aDHP to cross react at 29.5 %, 11 a-hydroxyprogesterone at 21.4 % and
2013-hydroxyprogesterone at 2.38 %. Two other progestins that were tested
reacted at < .4 % and the steroids estradio1-1711, androstenedione, cortisol, and
testosterone reacted at < .1%.
Figure 4 compares charcoal extracted and whole plasma standards that
were utilized to measure plasma progesterone concentrations of a pregnant
mare from Day 0 (ovulation) to Day 200. Plasma progesterone concentrations
measured using standards dilutedin charcoal extracted plasma remained
between 0 and 1 ng/ml from ovulation to approximately Day 40 of pregnancy.
This is highly unlikely to occur in a pregnant mare and is inconsistent with other
reports of plasma progesterone concentrations during this early pregnancy
period. A paired t-test was done with individual normal pregnant mare samples
andindicatedthattherewasadifferenceinplasmaprogesterone
concentrations when using standards diluted in charcoal extracted and whole
plasma (P < .05).Results from analysis of variance with repeated measures
indicated that there was a difference over time in plasma progesterone
concentrations of normal pregnant mares when using standards diluted in
charcoal extracted or whole plasma (P < .05).Overall, plasma progesterone
concentrations using standards diluted in whole plasma were higher and
consistentwithplasmaprogesteroneconcentrationsmeasuredby
radioimmunoassay and competitive binding radioassay as reported by Allen and27
Hadley (1973) and Holtan et al. (1975).
The reason as to why charcoal extraction appeared to interfere with the
measurement of plasma progesterone concentrations in the ELISA remains
unclear. However, it appears that standards and sample must be treated the
same for accurate results in the measurement of progesterone. This was also
true for samples that exceeded the readable portion of the standard curve and
were diluted and reassayed. The diluent used must be of the same matrix as
the samples to be assayed. Progesterone concentrations ranged from 50 to
300 ng/ml when diluted with PBS-BSA and 50 to 76 ng/ml when diluted with
whole plasma.
To further test and validate the use of whole plasma samples, a
commercially available RIA was used to test human serum (provided with the
kit), charcoal extracted or equine whole plasma as diluent for standards. From
Table 2, it appears that there was no difference between human serum and
whole plasma standards when used to measure progesterone concentrations
of whole plasma samples.Results from a one-way analysis of variance
indicatedthatthere was adifference between sampleprogesterone
concentrations measured using standards diluted in charcoal extracted plasma
versus whole plasma or human serum (P< .05).Further analysis by least
significant difference (LSD) indicated that progesterone measured by charcoal
extracted plasma was lower (P< .05) than that measured by human serum or
whole plasma (see Table 2).Correlation analysis of plasma progesterone28
concentrations of fourteen pregnant mare samples assayed by both RIA and
ELISA (using whole plasma standards) was highly significant (P < .05; r = .79).
In conclusion, the modified ELISA using equine whole plasma proved to be
a convenient, accurate and quick method for measuring plasma progesterone
concentrations during early pregnancy. The results of plasma progesterone
concentrations using standards diluted in equine whole plasma were similar and
consistent with previous reports.Despite a lowered sensitivity,the assay
provides an adequate range of detection for progesterone during early
pregnancy of the mare.
Normal mares
Individual plasma progesterone concentrations of four pregnant mares from
Day 0 (ovulation) to Day 200 can be seen in Figures5, 6, 7, and 8.It is
apparent from these Figures that there is day to day variation in plasma
progesterone concentrations within each mare and between mares. Although
progesterone concentrations are different for each mare there appears to be a
trendofincreasinganddecreasingprogesteroneconcentrationsat
approximately the same timeduring pregnancy.The overall plasma
progesterone concentrations of the mares were consistent with values
previously reported.
From Day 80 to approximately 150 plasma progesterone concentrations29
From Day 80 to approximately 150 plasma progesterone concentrations
increase for each mare, peaking at levels that ranged from 10 to 20 ng/ml.
This is normal and would be expected to occur due to accessory ovulations and
the formation of secondary CL. However, of the four mares, one mare had
exceedingly high plasma progesterone concentrations from Day 70 to 200
(Figure 8).These concentrations are also normal and presumably due to
accessory ovulations and the formation of secondary CL.
Figure 9 represents mean plasma progesterone concentrations of these four
normal pregnant mares from Day 0 (ovulation) to Day 200.Progesterone
concentrations increased following ovulation to approximately 10 ng/ml,
decreased and remained at approximately 6 ng/ml from Day 18 to 60. Starting
Day 80, levels increased and peaked at approximately 28 ng/ml by Day 100.
Standard error of the mean ranged from .175 to 8.0 up to Day 70 due to the
one mare with much higher progesterone after Day 70, and from 9.0 to 27.0
from Day 72 to 200.
Since it has been reported by Atkins et al. (1976) that 5aDHP increases
(along with progesterone after Day 40) and continues to increase or be
maintained until approximately 80 h prior to parturition, plasma progesterone
concentrations of all mares during this time may be overestimated due to the
cross reactivity of 5aDHP (cross reactivity at 23.9 %).30
Treated mares
The control mare (Figure 10a) which was given PGF2a on Day 15 of
pregnancy, appeared to completely resorb the embryonic vesicle within 48 h
following luteolysis. Plasma progesterone increased to approximately 9 ng/ml
on Day 8 postovulation then slowly declined to 6 ng/ml by Day 13. Within 48
h of PGF2a injection, progesterone concentrations declined from 6 ng/ml to 0
ng/ml. This is consistent with results reported by Noden et al. (1978), in which
progesterone concentrations of mares declined from 7.7 ± 1.1 ng/ml to .6 ±
.1 ng/ml within 48 h after injection with PGF2a.
Pregnancy was not maintained after luteolysis with PGF2a in either of the
two mares treated with 5aDHP. The first mare (Figure 10b) which was given
5aDHP starting Day 10 of pregnancy with PGF2a on Day 12, maintained
pregnancy until an abrupt loss on Day 23 as confirmed by ultrasound. The
second mare (Figure 10c) which was given 5aDHP starting on Day 13 of
pregnancy with PGF2a on Day 15, maintained pregnancy until Day 21.It
should be noted however, that the embryonic vesicle appeared to become
irregular in shape starting Day 17 and continued to change shape until complete
resorption by Day 21. This irregular shape was not observed to have occurred
in mare 1.Plasma progesterone concentrations in the mare which received
5aDHP starting Day 10 of pregnancy decreased to 3 ng /mI one day following
PGF2a injection.Levels were maintained at approximately 3 ng /mI and31
appeared to increase at Day 22. Plasma progesterone concentrations of the
mare which received 5aDHP starting Day 13 decreased toapproximately 1
ng/ml two days following PGF2a injection. Concentrations remained between
1 and 2 ng/ml until Day 20 and then appeared to increase.In both mares
treated with 5aDHP, plasma progesterone levels did not fall to 0 ng/ml
following luteolysis with PGF2a. Instead, plasma progesterone concentrations
ranged from 1 to 4 ng/ml and appeared to increase after detection of the
embryonic vesicle by ultrasound could not be confirmed.
The increase in plasma progesterone concentrations were most likely due
to the cross reactivity of 5aDHP (which was determined to be 23.9 %) and/or
incomplete luteolysis or subsequent estrus and ovulation. Atkins et al. (1976)
found that during early pregnancy both progesterone and 5aDHP decline from
Day 10 to 40 in a similar manner, after which time both progestins increase.
Inone study by Holtanetal.(1991),itwas reported that plasma
concentrations of 5aDHP during early pregnancy are similar to that of
progesterone.Itisonly toward the end of 150 days gestation that
progesterone alone declines and 5aDHP either continues to increase or is
maintained.
In summary, it appeared that 5aDHP did not maintain pregnancy. Until the
biological role of 5aDHP is determined, the question as to why pregnancy was
not maintained remains to be determined. Due to the high levels of 5aDHP at
the time of parturition as reported by Atkins et al. (1976) one may question the32
biological role of 5aDHP in initiating parturition rather than in maintaining
pregnancy.It appeared that 60 mg of exogenous 5aDHP is an inadequate
amount for maintaining pregnancy, although an adequate amount of exogenous
progesterone. In the future, it seems appropriate to at least test the effects of
a higher exogenous dose of 5aDHP and the effects on pregnancy maintenance.33
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Figure 1. ELISA progesterone standard curve with standards diluted
in charcoal extracted plasma, utilizing rabbit
anti-progesterone-11-BSA coated plates and
progesterone-3-CMO-horseradish peroxidase conjugate.34
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Figure 2. ELISA whole plasma standard curve utilizing rabbit
anti progesterone -1 1 -BSA coated plates and
progesterone-3-CMO-horseradish peroxidase conjugate.35
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Figure 3. Regression of added and recovered progesteronein plasma
quality controls of 5, 10 and 15 ng/ml using standardsdiluted
in whole plasma.30
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Figure 4. Comparison of progesterone standards diluted in whole plasma
vs charcoal-extracted plasma when used to measure progesterone
in plasma of a pregnant mare from Day 0 (ovulation) to Day 200.10
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Figure 5. Plasma progesterone concentrations of a pregnant mare from Day 0
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Figure 6. Plasma progesterone concentrations of a pregnant mare from Day 0
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Figure 7. Plasma progesterone concentrations of a pregnant mare from Day 0
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Figure 8. Plasma progesterone concentrations of a pregnant mare from Day 0
(ovulation) to Day 200. Note insert with expanded scale to Day 70.020406080100 120 140 160 180 200
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Figure 9. Mean plasma progesterone concentrations of four pregnant mares from Day
0 (ovulation) to Day 200. Standard error of the mean ranged from .175 to
8.0 up to Day 70, and from 9.0 to 27.0 from Day 72 to 200.42
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Figure 10. The effect of 5aDHP treatment on plasma progesterone and
pregnancy maintanence of mares after luteolysiswith PGF2a:
a) mare treated with 5 mg PGF2a Day 15; b) mare treated
with daily injections of 60 mg 5aDHP starting Day 10 and 5
mg PGF2a Day 12; c) mare treated with dailyinjections of 60
mg 5aDHP starting Day 13 and 5 mgPGF2a Day 15.43
TABLE 1. TABLE OF CROSS-REACTIVITIES OF STRUCTURALLY RELATED
STEROIDS.
Steroids Cross-Reactivity (%)
at 50% Binding
4-Pregnene-3,20-dione 100
5a-Pregnane-3,20-dione 23.9
313-Hydroxy-5a-pregnan-20-one < .1*
313-Hydroxy-5-pregnen-20-one < .5*
5a-Pregnane-313,2013-diol < .1*
5a-Pregnane-313,20a-diol <.1 *
5-Pregnene-313,2011-diol < .1*
20a-Hydroxy-5a-pregnan-3-one < .1*
Cholesterol <.1 *
*NonsignificantTABLE 2.COMPARISON OF PROGESTERONE QUANTITATION (ng/ml)
BASED ON COMMERCIAL RADIOIMMUNOASSAYUTILIZING
DIFFERENT SOURCES OF PLASMA FOR STANDARDS.
Plasma source
equine charcoal
sample human equine whole extracted
1 .3 0 0
2 5.8 6.9 1.0
3 11.4 13.0 2.5
4 10.6 12.2 2.3
5 3.5 4.4 .4
means 6.3a 7.3a 1.2b
44
a'13 Means with different superscripts are different (P < .05, least
significant difference).45
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Prior to the development of the modified solid phase competitive ELISA
using whole plasma, the following sandwich ELISA was attempted due to the
availability of commercial antibodies and conjugate. A sandwich ELISA is a
competitive assay which utilizes an antigen that is coated onto the plate,
followed by a double antibody system.This isin comparison to a direct
competitive assay system, which involves the use of only one antibody, which
is coated onto the plate.
Sandwich ELISA
Reagents. The following reagents and the company that they were
purchased from are as follows:The antigen, 4-pregnen-3,20-dione 3-0-
carboxymethyloxime:BSA (P4-3CMO-BSA) was purchased from Steraloids, Inc.
(Wilton, NH), the first antibody, sheep anti-progesterone-1 1 a-HS-BSA (#337)
was purchased from Colorado State University, and the second antibody, anti-
sheep IgG peroxidase conjugate, was purchased from Sigma Chemical Co. (St.
Louis, MO).Bovine serum albumin, polyoxyethylene-sorbitan monolaurate
(Tween20),hydrogen peroxide,citricacid,2,2'-azino-bis(3-ethylbenz-
thiazoline-6-sulfonic acid) (ABTS), and progesterone, were all purchased from
Sigma Chemical Company (St. Louis, MO). Horse serum (used in the blocking
solution) was purchased from Gibco Laboratories(GrandIsland,NY).
Disposable Immulon 4 flat bottomed polystyrene 96 well microelisa plates and50
plate sealers (8.26 x 13.34) were purchased from Dynatech Labs Inc.
(Chantilly, VA). A Titerek digital multichannel pipette and Titertek Multiskan
Plus II automatic plate reader were purchased from Flow Laboratories (Covina,
CA).
Stock solutions. The following stock solutions were prepared: 1) .05 M
bicarbonate buffer, pH 9.6; 2).1 M phosphate buffered saline, pH 7.0,
contained .1 % BSA (PBS-BSA); 3) blocking solution that contained 10 % horse
serum in .1 M PBS; 4) wash solution contained .05 % Tween 20 and .15 M
NaCI; 5) citrate buffer, pH 4.0; and, 6) substrate solution contained 1 ml of
2,2'-azino-bis(3-ethylbenz-thiazoline-6-sulfonicacid), 98.7 ml citrate buffer and
320 NI of a 8 M hydrogen peroxide solution and was made approximately 10
min before use.
Antigen.An initial 1 mg/ml stock solution of P4-3CMO-BSA was made in
.05 M bicarbonate buffer pH 9.6, and stored at 4 C until assay.
First antibody.A initial 1:20 dilution of sheep anti progesterone -1 1 a -HS -BSA
in .1 M PBS was made, with 20 pl aliquots stored at -70 C until assay.
Second antibody.The antibody enzyme conjugate which was diluted with
.1 M PBS, was diluted each day as needed for assay.51
Standards.A 1 mg/ml stock solution of progesterone was made in ethanol,
from which subsequent buffer (.1 M PBS-BSA) or plasma standards were made.
The plasma was obtained from a mare in estrus, and extracted with dextran
coated charcoal. Both buffer and plasma standards ranged from 25 to .195
ng/ml.
Nonspecific binding.Nonspecific binding was tested by adding 50 NI of the
following in duplicate to each plate: a) PBS only; b) PBS with first antibody; c)
PBS without first antibody; d) Plasma only; e) Plasma with first antibody; f)
plasma without first antibody; g) first antibody only; and, h) antigen only.
Assay.The various dilutions of antigen, first antibody, and second antibody
tested are as follows: a) 1:1,000, 1:2,000, 1:4,000; b) 1:10,000, 1:20,000,
1:40,000; c) 1:1,330, 1:2,000 and 1:4,000.Increasing and decreasing
amounts of substrate and hydrogen peroxide were added to the citrate buffer
to try and determine amounts necessary for optimal color development.
Disposable Immulon 4 flat bottomed polystyrene 96 well microelisa plates were
coated with 100 pl antigen diluted in .05 M bicarbonate buffer pH 9.6, covered
with plate sealers and stored at 4 C approximately 12 h before assay. To
remove excess unbound antigen, the plates were individually washed 5x with
wash solution, inverted and blotted dry.Fifty NI of blocking solution (10 %
horse serum in .1 M PBS-BSA) was then added to each well and allowed to52
incubate for approximately 1 h. Following washing and drying of the plates (as
described above), 50 p1 of standard (s) was added in duplicate, followed by an
additional 50 pl of the first antibody (diluted in .1 M PBS-BSA) and allowed to
incubate 2 additional hours. The plates were washed and blotted dry, followed
by 50 p1 of the second antibody (diluted in blocking solution), incubated for 1
h and then washed. One hundred p1 of substrate, which was made 10 min
before use, was added to each well on theplate and incubated for
approximately 45 min.All plates were read at 405 nm with a Titertek
Multiskan Plus II automatic plate reader. A standard curve was constructed by
plotting absorbance values against standards (ng/ml progesterone) using Graph
Pad Inplot version 3.1 (San Diego, CA).53
RESULTS AND DISCUSSION
Dilutions of 1:2,000 antigen, 1:20,000 first antibody, and 1:1,330 second
antibody produced standard curves forbuffer and plasma standards with
slopes of 1.23 and .81, respectively (see appendix Figure 1.). On each plate,
various reagents listed above were tested for nonspecific binding. It appeared
that little or no nonspecific binding was occurring. The assay was tested with
and without the use of blocking solution, which did not appear to be necessary.
Quality controls were not used since the assay was not ready to use routinely.
When comparing the charcoal extracted plasma standard curve to that of the
buffer standard curve, there appears to be some interference from the plasma
or from components in plasma that cause depression of the curve (see appendix
Figure 1).After 3 mo of trying to develop a plasma standard curve in which
results were very inconsistent, reagents for the direct ELISA became available
and development of a more simplified assay system was undertaken. After
development of the modified solid phase competitive ELISA in which results
indicated that standard and sample plasma must be treated the same, it seems
appropriate to suggest the followingmodifications that may enhance
development using whole plasma: a) Eliminate blocking solution and add PBS-
BSA to each well on the plate prior to standard or sample; b) use of whole
plasma as diluent for standards.1.0
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Appendix Figure 1. Sandwich ELISA comparing buffer and charcoal
extracted plasma standard curves utilizing
progesterone-3-CMO-BSA as the antigen, sheep
anti-progesterone-11-a-HS-BSA as the first
antibody, and anti-sheep IgG peroxidase conjugate
as the second antibody.